| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |